Protagonist Therapeutics
PTGX
#3740
Rank
โ‚ฌ2.64 B
Marketcap
44,38ย โ‚ฌ
Share price
11.55%
Change (1 day)
180.90%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2024 (TTM): โ‚ฌ0.29 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.30 Billion. In 2023 the company made a revenue of โ‚ฌ54.27 Million an increase over the revenue in the year 2022 that were of โ‚ฌ24.78 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.29 B442.11%
2023 โ‚ฌ54.27 M119.03%
2022 โ‚ฌ24.78 M2.58%
2021 โ‚ฌ24.15 M3.79%
2020 โ‚ฌ23.27 M11187.16%
2019 โ‚ฌ0.2 M-99.24%
2018 โ‚ฌ27.03 M61.67%
2017 โ‚ฌ16.72 M
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA